We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+4.27%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$7.45B
AUM Growth
+$600M
Cap. Flow
+$485M
Cap. Flow %
6.51%
Top 10 Hldgs %
47.64%
Holding
120
New
28
Increased
23
Reduced
22
Closed
26

Top Buys

Rank Stock Value
1
HSP
HOSPIRA INC
HSP
+$458M
2
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
+$409M
3
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$368M
4
BRCM
BROADCOM CORP CL-A
BRCM
+$274M
5
DTV
DIRECTV COM STK (DE)
DTV
+$157M

Top Sells

Rank Stock Value
1
PCYC
PHARMACYCLICS INC
PCYC
+$498M
2
TRW
TRW AUTOMOTIVE HOLDINGS CORP
TRW
+$301M
3
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
+$268M
4
BRSL
Brightstar Lottery PLC
BRSL
+$215M
5
HPP
Hudson Pacific Properties
HPP
+$157M

Sector Composition

Rank Sector Weight
1 Healthcare 20.31%
2 Communication Services 16.41%
3 Industrials 11.66%
4 Technology 11.04%
5 Consumer Discretionary 8.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABBV icon
51
AbbVie
ABBV
$468B
$19.1M 0.26%
+285,000
New +$18.6M
BABA icon
52
Alibaba
BABA
$286B
$18.2M 0.24%
221,000
– –
GTI
53
DELISTED
GRAFTECH INTERNATIONAL LTD
GTI
$17.4M 0.23%
+3,514,300
New +$16.6M
GRFS
54
Grifois
GRFS
$5.44B
$17.2M 0.23%
1,110,668
+531,292
+92% +$8.61M
A icon
55
Agilent Technologies
A
$44.9B
$17.2M 0.23%
445,000
-70,000
-14% -$2.91M
TTPH
56
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$16.5M 0.22%
17,400
+4,250
+32% +$3.47M
AAL icon
57
American Airlines Group
AAL
$9.15B
$16M 0.21%
400,000
– –
KN icon
58
Knowles
KN
$2.85B
$15.6M 0.21%
860,000
-949,000
-52% -$18.4M
WMGI
59
DELISTED
Wright Medical Group Inc
WMGI
$15.4M 0.21%
585,000
-70,000
-11% -$1.85M
NVET
60
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
$12.4M 0.17%
2,499,996
– –
ATML
61
DELISTED
ATMEL CORP
ATML
$12M 0.16%
+1,215,000
New +$10.7M
CLUB
62
DELISTED
Town Sports International Holdings, Inc.
CLUB
$11.8M 0.16%
4,060,082
– –
OREX
63
DELISTED
Orexigen Therapeutics, Inc.
OREX
$11.7M 0.16%
237,200
+90,500
+62% +$5.41M
BRLI
64
DELISTED
BIO-REFERENCE LABS INC-NEW-
BRLI
$10.1M 0.14%
+245,000
New +$8.78M
PCO
65
DELISTED
Pendrell Corporation - Class A
PCO
$9.27M 0.12%
6,768
– –
YELP icon
66
Yelp
YELP
$1.27B
$9.25M 0.12%
+215,000
New +$9.97M
DISH
67
DELISTED
DISH Network Corp.
DISH
$9.14M 0.12%
+135,000
New +$9.43M
LRMR icon
68
Larimar Therapeutics
LRMR
$434M
$7.96M 0.11%
19,167
+8,334
+77% +$3.49M
STML
69
DELISTED
Stemline Therapeutics, Inc.
STML
$7.92M 0.11%
672,562
– –
GILD icon
70
Gilead Sciences
GILD
$181B
$7.9M 0.11%
+67,500
New +$7.38M
INXN
71
DELISTED
Interxion Holding N.V.
INXN
$7.54M 0.1%
272,500
-57,500
-17% -$1.71M
GWPH
72
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$7.37M 0.1%
+60,000
New +$6.81M
PRE
73
DELISTED
PARTNERRE LTD
PRE
$7.08M 0.1%
+55,112
New +$7.11M
KMI.WS
74
DELISTED
Kinder Morgan Inc
KMI.WS
$6.75M 0.09%
2,500,000
– –
VIRX
75
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$6.51M 0.09%
+10,301
New +$5.47M
1 2
3
4 5

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2015 Portfolio in Review

As of Q2 2015, Thomas Steyer held 120 positions worth $7.45B, up 8.8% from $6.85B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Thomas Steyer deployed $485M of net new capital in Q2 2015, opening 28 new positions and adding to 23 existing holdings. Its largest new stake was CATAMARAN CORP COM STK (CDA): 6,817,500 shares worth $416M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 10% a quarter earlier, followed by Communication Services and Industrials.

On the sell side, the largest reduction was Hudson Pacific Properties, an estimated $157M trimmed.

  • Thomas Steyer's largest Q2 2015 buy was CATAMARAN CORP COM STK (CDA): 6,817,500 shares worth $416M.
  • Thomas Steyer added most to HOSPIRA INC in Q2 2015, an estimated $458M increase.
  • Thomas Steyer's biggest Q2 2015 reduction was Hudson Pacific Properties, cutting an estimated $157M.
  • Thomas Steyer fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $498M.
  • Thomas Steyer's ten largest holdings make up 48% of its $7.45B portfolio in Q2 2015.
  • Thomas Steyer opened 28 new positions and closed 26 in Q2 2015.
  • Thomas Steyer's portfolio value rose 8.8% quarter-over-quarter to $7.45B.

Based on Farallon Capital Management's 13F filing for Q2 2015, filed 14 Aug 2015.